Neuro-Behçet syndrome presenting as acute meningeal syndrome.
Behçet's disease is a systemic vasculitic disease characterized mainly by recurrent oral and genital aphthous ulcers, uveitis and skin findings. Central nervous system involvement is a serious manifestation. A case of acute meningeal syndrome secondary to Behçet's disease is presented. Behçet's disease should always be considered in differential diagnosis of acute meningeal syndrome without signs of viral infection, particularly in the context of multisystem manifestations.
Kara
Bülent
B
Pediatrics, Kocaeli University Medicine Faculty, Kocaeli, Turkey. bulentkara@excite.com
Somer
Ayper
A
Pişkin
Sanem
S
Aydinli
Nur
N
Salman
Nuran
N
Yalçin
Işik
I
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D001528:Behcet Syndrome / Q000150:complications* / Q000175:diagnosis* / Q000188:drug therapy; D002648:Child; D003078:Colchicine / Q000627:therapeutic use; D003937:Diagnosis, Differential; D006074:Gout Suppressants / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use; D008297:Male; D008582:Meningitis, Aseptic / Q000175:diagnosis / Q000209:etiology*; D008775:Methylprednisolone / Q000627:therapeutic use; D010296:Parietal Lobe / Q000473:pathology; D011994:Recombinant Proteins
D000893:Anti-Inflammatory Agents; D006074:Gout Suppressants; D007166:Immunosuppressive Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D001379:Azathioprine; D001241:Aspirin; D003078:Colchicine; D008775:Methylprednisolone